Test Story

By: NewsUSA

March 27, 2025 at 20:00 PM EDT

(NewsUSA) - For more details, including important safety information, on VenaSeal, visit: https://www.medtronic.com/breakfree.

Sources

Gloviczki P, Comerota AJ, Dalsing MC, et al. The care of patients with varicose veins and associated chronic venous diseases: Clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg. 2011;53(5 Suppl):2S–48S. doi: 10.1016/j.jvs.2011.01.079.

Mayo Clinic: Varicose Veinshttps://www.mayoclinic.org/diseases-conditions/varicose-veins/symptoms-causes/syc-20350643

National Heart Lung and Blood Institute: Varicose Veins https://www.nhlbi.nih.gov/health/varicose-veins

Morrison N, Gibson K, McEnroe S, et al. Randomized trial comparing cyanoacrylate embolization and radiofrequency ablation for incompetent great saphenous veins (VeClose). J Vasc Surg. 2015;61(4):985–994. doi: 10.1016/j.jvs.2014.11.071.

Proebstle T, Alm J, Dimitri S, et al. Three-year follow-up results of the prospective European multicenter cohort study on cyanoacrylate embolization for treatment of refluxing great saphenous veins. J Vasc Surg Venous Lymphat Disord. 2021;9(2):329–334. doi: 10.1016/j.jvsv.2020.05.019.

Almeida JI, Javier JJ, Mackay EG, Bautista C, Cher DJ, Proebstle TM. Thirty-sixth-month follow-up of first-in-human use of cyanoacrylate adhesive for treatment of saphenous vein incompetence. J Vasc Surg Venous Lymphat Disord. 2017;5(5):658–666. doi: 10.1016/j.jvsv.2017.03.016.

Symbol	Price	Change (%)
AMZN	244.41	+1.37 (0.56%)
AAPL	268.47	-1.30 (-0.48%)
AMD	233.54	-4.16 (-1.75%)
BAC	53.20	-0.09 (-0.17%)
GOOG	279.70	-5.64 (-1.98%)
META	621.71	+2.77 (0.45%)
MSFT	496.82	-0.28 (-0.06%)
NVDA	188.15	+0.07 (0.04%)
ORCL	239.26	-4.54 (-1.86%)
TSLA	429.52	-16.39 (-3.68%)

Symbol

Price

Change (%)

AMZN

244.41

+1.37 (0.56%)

AAPL

268.47

-1.30 (-0.48%)

AMD

233.54

-4.16 (-1.75%)

BAC

53.20

-0.09 (-0.17%)

GOOG

279.70

-5.64 (-1.98%)

Test Story

More News

Recent Quotes